Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Healio

17:25 EST 23rd November 2017 | BioPortfolio

Here are the most relevant search results for "Healio" found in our extensive news archives from over 250 global news sources.

More Information about Healio on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Healio for you to read. Along with our medical data and news we also list Healio Clinical Trials, which are updated daily. BioPortfolio also has a large database of Healio Companies for you to search.

Showing News Articles 1–25 of 2,200+ from Healio

Wednesday 22nd November 2017

Drinking coffee reduces risk for death, negative health outcomes

Consuming coffee lowered the risk for death and a broad spectrum of health outcomes, according to a report recently published in BMJ.“It is important to systematically assess the totality of higher level evidence of the effects of coffee consumption on all health outcomes,” Robin Poole, MB, ChB, MSc, of the academic unit of primary care and population sciences, University of Southampton, Unite...

VIDEO: MicroPulse technology allows safe treatment of glaucoma, retina

NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, David Gossage, DO, shares pearls on how to use MicroPulse technology (Iridex) for glaucoma and retina treatments.

Bone marrow edema in lower spine common in young athletes

Ulrich WeberSAN DIEGO — Bone marrow edema is common in the sacroiliac joints of both amateur and professional young athletes, with damage most frequently seen in the posterior lower ilium, according to research presented at the American College of Rheumatology Annual Meeting.“There are two problems in spondyl science — one is early recognition of the disease,” Ulrich Weber, MD, a researche...

Should children with type 1 diabetes and dyslipidemia be treated with lipid-lowering medications?

Click here to read the Cover Story, "Experts push to move ‘beyond HbA1c’ as main measure of diabetes outcomes."Cardiovascular disease remains the leading cause of mortality in people with diabetes. This includes patients diagnosed with type 1 diabetes in childhood. Lipid-lowering medications, including statins, fibrates, bile acid sequestrants and newer medications, offer several effective opt...

Back-to-basics approach to diabetic neuropathy can prevent, relieve painful symptoms

Diabetic neuropathy remains one of the most common chronic complications of both type 1 and type 2 diabetes. According to the National Institute of Neurological Disorders and Stroke, about 60% to 70% of people with diabetes have mild to severe forms of nervous system damage that can affect sensory, motor and autonomic nerves.Diabetic neuropathy can present in any number of painful ways: a superfic...

Daily foot care can prevent later problems

In this issue, Susan Weiner, MS, RDN, CDE, CDN, talks with podiatrist Mark Hinkes, DPM, about foot problems that commonly affect people with diabetes.Hinkes: Neuropathy, vasculopathy and a faulty immune system affect the feet of patients with diabetes and can lead to needless and preventable foot pathology. People with diabetes on a daily basis should be visually and manually inspecting both their...

As obesity rate rises, ‘double diabetes’ looms large

An October report from the CDC’s National Center for Health Statistics revealed a startling increase in the prevalence of obesity in the U.S., with rates now approaching 20% in children and 40% in adults for 2015-2016.The growing epidemic has not spared those with type 1 diabetes. Today, obesity prevalence is as high or higher among patients with type 1 diabetes as in the general population. Acc...

FDA approves Light Adjustable Lens from RxSight

The FDA has approved the Light Adjustable Lens and Light Delivery Device from RxSight, according to an FDA press release.This is the first medical device system that can make adjustments to the lens power after cataract surgery to correct refractive errors.The IOL is made of a material that will react to UV light, which the Light Delivery Device provides, at 17 to 21 days after surgery, according ...

De-escalating dose of bevacizumab may be effective in treating ROP

NEW ORLEANS — A dose of intravitreal bevacizumab as low as 0.031 mg was successful in treating acute, severe retinopathy of prematurity in a small cohort of infant patients, a speaker said here.“Doses as low as 5% of what was used and considered the standard dose in the BEAT-ROP study were successful in nine out of nine infants, although some infants required additional treatment,” David K. ...

FDA: Limbrel linked to 'potentially life-threatening' problems

The FDA is investigating the drug Limbrel, a capsule-based product currently marketed as a medical food to manage the metabolic processes associated with osteoarthritis, for what the administration calls “serious adverse events.”Limbrel (flavocoxid, Primus Pharmaceuticals) has been linked to a total of 194 of adverse events, including two “serious and potentially life-threatening” medical ...

VIDEO: Aesthetic lower eyelid surgery minimally invasive for best results

NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, David B. Samimi, MD, of the USC Roski Eye Institute, discusses newer minimally invasive lower eyelid surgery techniques for better aesthetic outcomes

Tuesday 21st November 2017

Xen gel stent ‘transformative’ to glaucoma practice

NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, Nathan Radcliffe, MD, of New York Eye and Ear, discusses his implementation of the Allergan Xen gel stent for treating patients with refractory glaucoma or those in need of a minimally invasive glaucoma procedure to lower IOP. 

ACR asks CMS to 'remove barriers' between small practices, alternative payment models

David DaikhThe American College of Rheumatology has called on CMS to “remove barriers” that it says hinder subspecialists and small practices from participating in alternative payment models. The organization issued its statement in the form of a comment letter in response to a CMS Innovation Center New Direction Request for Information.“We believe the more rheumatologists who are able to pa...

Second Sight reports $6.7 million quarterly net loss

Second Sight Medical Products reported a net loss of $6.7 million, or $0.12 per share, in the third quarter of 2017 compared with a net loss of $8.5 million, or $0.20 per share, in the same quarter of last year, according to a press release.Total revenue increased from $1.2 million in 2016’s third quarter to $1.6 million in 2017’s third quarter, which was attributed to a higher revenue per Arg...

Lesions on MRI absent symptoms, history may yield false spondyloarthritis diagnosis

  Thomas RensonSAN DIEGO – A physical exam and complete medical history should supplement MRI results when making a diagnosis of spondyloarthritis, according to findings presented at the ACR Annual Meeting.Study results from Thomas Renson, MD, a researcher and PhD student at Ghent University in Belgium, and colleagues revealed a “markedly high prevalence” of bone marrow edema and structural...

Working with clinical trials a common theme for KOL migration into industry

Richard l. LindstromNEW ORLEANS — A large number of doctors are joining companies as chief medical officers, OSN Chief Medical Editor Richard L. Lindstrom, MD, said in remarks at the Ophthalmology Innovation Summit, where he introduced a panel discussion highlighting the migration of key opinion leaders into industry.“We have a significant example of that [on the panel] here,” Lindstrom said...

ACP: Improving health care price transparency ‘vital’

Jack EndeIncreasing access to meaningful information, including price, cost and quality data on health care services, can aid in efforts to improve health care price transparency and may help mend the health care fragmentation, according to a new policy paper by the ACP.“Our health care system is undergoing multiple shifts: an increase in insured patients, moving payments to quality-based system...

Intranasal tear neurostimulation increases acute tear production

Edward J. HollandNEW ORLEANS — Data from two studies reinforce the finding that intranasal tear neurostimulation results in significantly increased acute tear production compared with either active extranasal or sham intranasal applications, a speaker said.“As we’ve learned over the last few years, stimulation of the trigeminal afferent nerve in the nasal mucosa triggers the nasolacrimal ref...

VIDEO: Atacicept is a 'potential, exciting' treatment for lupus

SAN DIEGO — At the American College of Rheumatology Annual Meeting, Joan Merrill, MD, spoke about a study that she said is further demonstration that atacicept should continue being developed as a potential treatment for lupus. According to Merrill, the results also suggest that measurements of low-disease activity may represent not just clinically meaningful endpoints, but may also “work as e...

Monday 20th November 2017

VIDEO: Single-pass, four-throw pupilloplasty technique assists in angle closure glaucoma

NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, Amar Agarwal, MS, FRCS, FRCOphth, discusses the single-pass, four-throw pupilloplasty technique he has been using in narrow-angle and closed-angle glaucoma cases to drastically lower IOP.

Single bimatoprost implant controls IOP at 2 years in some patients

NEW ORLEANS — All doses and strengths of Allergan’s bimatoprost sustained release implant demonstrated efficacy in patients with open-angle glaucoma, E. Randy Craven, MD, said at the American Academy of Ophthalmology meeting.Craven gave 24-month results of the phase 1/2 clinical trial of Bimatoprost SR, which was undertaken to evaluate the safety and effectiveness of the single use treatment i...

EULAR, ACR offer new classification criteria for lupus

SAN DIEGO — The European League Against Rheumatism and the American College of Rheumatology have presented a draft of their new classification criteria for systemic lupus erythematosus, which researchers said provides greater specificity and sensitivity, and will more accurately identify patients for clinical trials.“We have defined a system of criteria, which produces a measure of the relativ...

Wills Eye Hospital and OSN want ophthalmologists’ feedback

Wills Eye Hospital and Ocular Surgery News are asking ophthalmologists to weigh in on the future of ophthalmic practice by completing a brief survey.Responses to the survey, which should take approximately 20 minutes to complete, will help show trends in the field, both current and future. Your feedback will be confidential, and survey results will only appear in an aggregated fashion.Participants...

AACE, Endocrine Society Call for insulin affordability initiatives

The American Association of Clinical Endocrinologists and the Endocrine Society called on the American Medical Association to address the rising cost of insulin and the associated burden placed on patients with diabetes, the organizations announced in a press release.At the 2017 Interim Meeting of the AMA House of Delegates, AACE and the Endocrine Society introduced a joint resolution requesting t...

IV drug users respond well to endophthalmitis treatment

Intravenous drug users who had endogenous endophthalmitis responded better to treatment than those who did not use drugs, according to a retrospective medical record review.The researchers said those who did not use drugs fared worse due to more chronic comorbidities and older age.Investigators chose a large medical center in New Hampshire for its patient population, as the age-related rate of dea...


Quick Search
Advertisement
 

News Quicklinks